Research Article
Volume 10 Issue 10 - 2021
Evolutionary Aspects of Newborns Under 1500g Treated with Fluoroquinolones in Libreville, Gabon
Kuissi Kamgaing Eliane1,2*, S Minto'o Rogombe1, R Koumba Maniaga1,2, A Lembet Mikolo1,2, E Mintsa Mi Kama1,2, I Busugu Bu Mbadinga1,2 and S Ategbo1,2
1Department of Pediatrics, University of Health Sciences, BP, Libreville, Gabon
2Children Pole, Mother-Child Hospital-University Center Jeanne Ebori Foundation of Libreville, BP, Libreville, Gabon
*Corresponding Author: Kuissi Kamgaing Eliane, Professor, Department of Pediatrics, University of Health Sciences, BP, Libreville, Gabon.
Received: September 06, 2021; Published: September 18, 2021


Introduction: The resistance of germs responsible for neonatal infections sometimes requires the use of fluoroquinolones that are not indicated at this age. Our goal was to assess the short- and medium-term fate of newborns under 1500g treated with fluoroquinolone in Libreville.

Methodology: Case control study, over a period of 3 years (January 2015 - December 2018). The cases consisted of newborns under 1500g treated for neonatal infection with fluoroquinolones. Controls were newborns under 1500g treated for neonatal infection with other antibiotic families. The parameters studied were urea, creatinine, blood glucose of cases at Day0, Day10 and Day30 post-treatment. We compared anthropometric parameters and motor acquisition at 3, 6 and 12 months of the two groups.

Results: In the fluoroquinolones group, sepsis was the most observed localization (60%) and E. coli the most found germ (28%). The average time to the introduction of fluoroquinolones was 15d ± 7d. The most widely used molecule was Ciprofloxacin (68%). The most observed side effect was hypoglycaemia (28%) and an increase in serum creatinine (p = 0.006) and uremia (p = 0.0013) was observed on Day10 post-treatment. We did not observe any musculoskeletal manifestations. The evolution of anthropometric parameters and motor development was comparable in the 2 groups.

Conclusion: Fluoroquinolones motivated by the consideration of benefit/risk are well tolerated in newborns under 1500g.

Keywords: Low Weight Newborn; Fluoroquinolones; Libreville-Gabon


  1. Muylaert A and Mainil JG. “Résistances bactériennes aux antibiotiques: les mécanismes et leur « contagiosité”. Annales de Médecine Vétérinaire 156 (2012): 109-123.
  2. Brun-Buisson C., et al. “Résistance bactérienne aux antibiotiques: épidémiologie et prospective”. Science et Pseudo-Sciences Antibiotiques (2018): 325.
  3. Organisation mondiale de la santé. Plan d'action mondial sur la résistance aux antimicrobiens. OMS (2015).
  4. Organisation mondiale de la santé. Pourquoi un Défi mondial sur les infections nosocomiales. OMS (2020).
  5. Kuissi Kamgaing E., et al. “Epidemiological Aspects and Evolution of Nosocomial Infection in the Neonatology Unit of Angondje Teaching Hospital”. The Neonatal and Pediatric Medicine1 (2019): 182.
  6. Andrianarivelo AM., et al. “Profil bactériologique des infections néonatales à l’unité de réanimation néonatale de la Maternité de Befelatanana. Revue d’Anesthésie-Réanimation et de Médecine d’Urgence 2 (2010): 1-4.
  7. Zaidi AKM. “Hospital acquired néonatal infections in developing countries”. Lancet 365 (2005): 1175-1188.
  8. Chabni N., et al. “Facteurs de risque de l’infection nosocomiale au niveau du service de néonatologie polyvalente de l’établissement hospitalier spécialisé mère-enfant de Tlemcen à l’Ouest algérien, « étude cas-témoins”. Journal de Pédiatrie et de Puericulture 28 (2015): 71-79.
  9. Aujard Y and Bottineau MC. “Épidémiologie mondiale des infections néonatales”. In. Aujard Y, Elservier Masson. Infection néonatale: bactériennes, mycosique, parasitaires et virales. Paris (2015): 11-18.
  10. Chemsi M., et al. “Incidence des infections bacteriennes nosocomiales. Hôpital d’enfants Abderrahim Harouchi, CHU Ibn Rochd, Casablanca, Maroc”. Journal de Pédiatrie et de Puericulture1 (2013): 11-18.
  11. Jatsho J., et al. “Clinical and Bacteriological Profile of Neonatal Sepsis: A Prospective Hospital-Based Study”. International Journal of Pediatrics (2020).
  12. Hassuna NA., et al. “Extensively-Drug Resistant Klebsiella pneumoniae Recovered From Neonatal Sepsis Cases From a Major NICU in Egypt”. Frontiers in Microbiology 11 (2020): 1375.
  13. Dalal P., et al. “Bacteriological profile and antimicrobial sensitivity pattern in neonatal sepsis: a study from North India”. International Journal of Research in Medical Sciences 4 (2017): 1541-1545.
  14. Cottineau MC. “Infection néonatales dans les pays en voie de développement”. In. Aujard Y, Elservier Masson. Infection néonatale: bactériennes, mycosique, parasitaires et virales. Paris (2015): 204-223.
  15. Dutta S., et al. “Ciprofloxacin administration to very low birth weight babies has no effect on linear growth in infancy”. Journal of Tropical Pediatrics 52 (2006): 103-106.
  16. Kuissi Kamgaing E., et al. “Colonisation digestive par des germes nosocomiaux des nouveau-nés hospitalisés au CHU d’Angondjé: aspects épidémiologiques et facteurs de risqué”. Journal de Pédiatrie Et De Puériculture 30 (2017): 193-200.
  17. Chaudhari S., et al. “Safety profile of ciprofloxacin used for neonatal septicemia”. Indian Pediatrics 12 (2004): 1246-1251.
  18. Masoumi B., et al. “Safety Profile of Using Ciprofloxacin in Paediatrics: A Systematic Review and Meta-Analysis”. Journal of Pediatrics Review 3 (2019): 129-140.
  19. Larouche G. “Les quinolones: des années soixante à aujourd’hui”. Pharmactuel2 (2001): 40-46.
  20. Patel K and Goldman JL. “Safety Concerns Surrounding Quinolone Use in Children”. The Journal of Clinical Pharmacology9 (2016): 1060-1675.
  21. Jackson MA and Schutze G E. “AAP committee on infectious diseases. The Use of Systemic and Topical Fluoroquinolones”. Pediatrics5 (2016).
  22. Wang JG., et al. “Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children”. Medicine34 (2020).
  23. Forsythe CT and Ernst ME. “Do fluoroquinolones commonly cause arthropathy in children?”. Canadian Journal of Emergency Medicine6 (2007): 459-462.
  24. World Health Organization. Model List of Essential Medicines. 7th List for Children. WHO (2019).
  25. Maria Pacifici G and Marchini G. “Clinical Pharmacology of Ciprofloxacin in Neonates: Effects and Pharmacokinetics”. International Journal of Pediatrics6 (2017): 5023-5041.
  26. Zhao W., et al. “Population Pharmacokinetics of Ciprofloxacin in Neonates and Young Infants Less than Three Months of Age”. Antimicrobial Agents and Chemotherapy 11 (2014): 6572-6580.
  27. Oulmaati A., et al. “L’apport des quinolones en néonatologie (à propos de 21 cas)”. Journal De Pédiatrie Et De Puericulture 4 (2013): 193-197.
  28. Kaguelidou F., et al. “Ciprofloxacin Use in Neonates A Systematic Review of the Literature”. The Pediatric Infectious Disease Journal 2 (2011): 29-37.
  29. Adefurin A., et al. “Ciprofloxacin safety in paediatrics: a systematic review”. Archives of Disease in Childhood9 (2011): 874-880.
  30. Aggarwal P., et al. “Multiple dose pharmacokinetics of ciprofloxacin in preterm babies”. Indian Pediatrics10 (2004): 1001-1007.
  31. Aujard Y. “Posologie des anti-infectieux (antibiotiques, antifongiques, antiviraux)”. In. Aujard Y, Elservier Masson. Infection néonatale: bactériennes, mycosique, parasitaires et virales. Paris: (2015): 235-242.
  32. Kim Y., et al. “Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study”. Scientific Reports (2019): 9.
Citation: Kuissi Kamgaing Elianel., et al. “Evolutionary Aspects of Newborns Under 1500g Treated with Fluoroquinolones in Libreville, Gabon”. EC Paediatrics 10.10 (2021): 55-62.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 13, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.